This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Naevi

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

These localised collections of melanocytes are extremely common and usually first appear during childhood. They increase during adolescence and may decrease in the elderly. Histological changes may occur during puberty and pregnancy. Most people have 5-20 melanocytic naevi. Many are acquired; some are inherited.

The importance of pigmented naevi lies in the identification of those with potential for malignant change - for example, include enlargement, altered pigmentation - increased or decreased - asymmetry, irregularity of the surface or edge, inflammation, bleeding, ulceration, itch or nodularity.

Individual melanocytic lesions may be clinically evaluated by (1):

  • examination with the naked eye
  • dermoscopy
  • photographic comparison.

Only photographic comparison helps in monitoring change in a particular lesion, which is important when observing for malignant transformation.

Excision is indicated if malignant transformation is suggested or for cosmetic reasons. However, less than 30% of melanomas arise from pre-existing naevi.

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.